| Literature DB >> 32581613 |
Dounia Marbouh1, Iman Khaleel1, Khawla Al Shanqiti1, Maryam Al Tamimi1, Mecit Can Emre Simsekler1,2, Samer Ellahham3, Deniz Alibazoglu3, Haluk Alibazoglu4.
Abstract
PURPOSE: Patient no-shows are long-standing issues affecting resource utilization and posing risks to the quality of healthcare services. They also lead to loss of anticipated revenue, particularly in services where resources are expensive and in great demand.Entities:
Keywords: no-shows; overbooking; patient appointment; predictive analytics; quality; resource utilization; scheduling policy
Year: 2020 PMID: 32581613 PMCID: PMC7280239 DOI: 10.2147/RMHP.S232114
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
X-Ray No-Show Heatmap
| Sunday | Monday | Tuesday | Wednesday | Thursday | Friday | Saturday | Hourly Avg | |
|---|---|---|---|---|---|---|---|---|
| 0 | – | 2% | – | 3% | 2% | 2% | 3% | 2% |
| 7 | 3% | – | – | – | 2% | – | – | 2% |
| 8 | 2% | 1% | 5% | 2% | 1% | 1% | – | 2% |
| 9 | 4% | – | 6% | – | 1% | 1% | - | 3% |
| 10 | 4% | 1% | 4% | 3% | – | – | 1% | 3% |
| 11 | 5% | 2% | 4% | 1% | 1% | – | – | 3% |
| 12 | 0% | 1% | – | – | 0% | – | 1% | 1% |
| 13 | 10% | 2% | 9% | 3% | 3% | – | – | 6% |
| 14 | 6% | 2% | 9% | 1% | 2% | – | – | 4% |
| 15 | 8% | 0% | 8% | 1% | 5% | – | – | 5% |
| 16 | 3% | – | 3% | – | – | 1% | – | 3% |
| 17 | – | 1% | 1% | – | – | – | – | 1% |
| 18 | – | 1% | - | – | – | – | – | 1% |
| 21 | – | – | 1% | – | – | – | – | 1% |
| Avg | 5% | 1% | 6% | 2% | 2% | 1% | 1% | 3% |
MRI No-Show Heatmap
| Sunday | Monday | Tuesday | Wednesday | Thursday | Friday | Saturday | Hourly Avg | |
|---|---|---|---|---|---|---|---|---|
| 0 | 33% | 40% | 67% | 100% | 83% | – | 63% | |
| 7 | 33% | 24% | 33% | 23% | 19% | 27% | 31% | 27% |
| 8 | 21% | 34% | 27% | 8% | 27% | 30% | 22% | 26% |
| 9 | 21% | 24% | 31% | 22% | 21% | 27% | 22% | 24% |
| 10 | 12% | 13% | 15% | 14% | 20% | 14% | 19% | 15% |
| 11 | 10% | 11% | 10% | 17% | 9% | 14% | 11% | 12% |
| 12 | 13% | 19% | 15% | 14% | 8% | – | – | 13% |
| 13 | 11% | 16% | 14% | 5% | 12% | 16% | 13% | 12% |
| 14 | 23% | 9% | 15% | 15% | 7% | 20% | 9% | 14% |
| 15 | 14% | 16% | 20% | 12% | 11% | 15% | 17% | 15% |
| 16 | 14% | 16% | 22% | 15% | 25% | 27% | 29% | 21% |
| 17 | 28% | 21% | 22% | 20% | 20% | 15% | 37% | 23% |
| 18 | 8% | 21% | 11% | 17% | 3% | 17% | 32% | 14% |
| 19 | 19% | 29% | 27% | 21% | 20% | – | – | 24% |
| 20 | 24% | 23% | 27% | 16% | 23% | – | – | 23% |
| 21 | 23% | 19% | 27% | 22% | 31% | – | – | 24% |
| 22 | 12% | 28% | 35% | 18% | 14% | – | – | 22% |
| 23 | 22% | – | 14% | 50% | 63% | – | – | 36% |
| Avg | 19% | 20% | 23% | 17% | 18% | 21% | 22% | 20% |